21 CFR § 812.42 Investigational Device Exemptions

§ 812.42 FDA and IRB approval.

Current through Sep 8, 2026 · Read all of Part 812

A sponsor shall not begin an investigation or part of an investigation until an IRB and FDA have both approved the application or supplemental application relating to the investigation or part of an investigation.

[46 FR 8957, Jan. 27, 1981]

← § 812.40 General responsibilities of sponsors.§ 812.43 Selecting investigators and monitors. →